The following represents disclosure information provided by faculty of the educational and scientific sessions. The Committee have reviewed all presented disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Does the Road to Cure Myeloma End with Minimal Residual Disease?
 
Suzanne Lentzsch
 
Employment - No Relationships to Disclose
 
Leadership - No Relationships to Disclose
 
Stock and Other Ownership Interests - No Relationships to Disclose
 
Honoraria - No Relationships to Disclose
 
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca; BMS; GlaxoSmithKline; Janssen; Kite, a Gilead company; Pfizer; Regeneron; Sanofi
 
Speakers' Bureau - IDEOlogy Health; Leukemia, Lymphoma and Myeloma; PeerView; PER (Physician Education Resource); Springer Nature
 
Research Funding - Sanofi
 
Patents, Royalties, Other Intellectual Property - Patent 11-1F4 mAb for use in AL Amyloidosis
 
Expert Testimony - No Relationships to Disclose
 
Travel, Accommodations, Expenses - Regeneron
 
Other Relationship - No Relationships to Disclose